367 related articles for article (PubMed ID: 34216021)
1. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
[TBL] [Abstract][Full Text] [Related]
2. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
Gong L; Whirl-Carrillo M; Klein TE
Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
4. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
[TBL] [Abstract][Full Text] [Related]
5. PharmGKB: A worldwide resource for pharmacogenomic information.
Barbarino JM; Whirl-Carrillo M; Altman RB; Klein TE
Wiley Interdiscip Rev Syst Biol Med; 2018 Jul; 10(4):e1417. PubMed ID: 29474005
[TBL] [Abstract][Full Text] [Related]
6. PGxMine: Text mining for curation of PharmGKB.
Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
[TBL] [Abstract][Full Text] [Related]
7. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
[TBL] [Abstract][Full Text] [Related]
8. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
Owen RP; Altman RB; Klein TE
Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
[TBL] [Abstract][Full Text] [Related]
9. Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine.
Mehta D; Uber R; Ingle T; Li C; Liu Z; Thakkar S; Ning B; Wu L; Yang J; Harris S; Zhou G; Xu J; Tong W; Lesko L; Fang H
Drug Discov Today; 2020 May; 25(5):813-820. PubMed ID: 32032705
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic Biomarkers: an FDA Perspective on Utilization in Biological Product Labeling.
Schuck RN; Grillo JA
AAPS J; 2016 May; 18(3):573-7. PubMed ID: 26912182
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics Clinical Annotation Tool (PharmCAT).
Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE
Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493
[TBL] [Abstract][Full Text] [Related]
12. Variability of Pharmacogenomics Information in Drug Labels Approved by Different Agencies and its Ethical Implications.
Güner MD; Ekmekci PE; Kurtoglu B
Curr Drug Saf; 2022; 17(1):47-53. PubMed ID: 34315387
[TBL] [Abstract][Full Text] [Related]
13. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
Hafner S; Haubensak S; Paul T; Zolk O
Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
[No Abstract] [Full Text] [Related]
14. Enabling the curation of your pharmacogenetic study.
McDonagh Em; Whirl-Carrillo M; Altman RB; Klein TE
Clin Pharmacol Ther; 2015 Feb; 97(2):116-9. PubMed ID: 25670512
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomic biomarker information differences between drug labels in the United States and Hungary: implementation from medical practitioner view.
Varnai R; Szabo I; Tarlos G; Szentpeteri LJ; Sik A; Balogh S; Sipeky C
Pharmacogenomics J; 2020 Jun; 20(3):380-387. PubMed ID: 31787752
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of a pharmacogenomics information resource for pharmacists.
Romagnoli KM; Boyce RD; Empey PE; Ning Y; Adams S; Hochheiser H
J Am Med Inform Assoc; 2017 Jul; 24(4):822-831. PubMed ID: 28339805
[TBL] [Abstract][Full Text] [Related]
17. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical impact of pharmacogenomics knowledge involved in CPIC guidelines on Chinese pediatric patients.
Qin W; Du Z; Xiao J; Duan H; Shu Q; Li H
Pharmacogenomics; 2020 Feb; 21(3):209-219. PubMed ID: 31967514
[No Abstract] [Full Text] [Related]
19. A Pharmacogenomics-Based In Silico Investigation of Opioid Prescribing in Post-operative Spine Pain Management and Personalized Therapy.
Lewandrowski KU; Sharafshah A; Elfar J; Schmidt SL; Blum K; Wetzel FT
Cell Mol Neurobiol; 2024 May; 44(1):47. PubMed ID: 38801645
[TBL] [Abstract][Full Text] [Related]
20. [Personalised pharmacogenetics. Evidence-based guidelines and clinical application of pharmacogenetic diagnostics].
Stingl JC; Brockmöller J
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Nov; 56(11):1509-21. PubMed ID: 24170080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
